Overview
Key stats
Fundamentals Sep 12- Open
- $398.47
- 52-wk high
- $554.58
- High
- $426.83
- 52-wk low
- $353.99
- Low
- $396.00
- Prev close
- $402.02
- Mkt cap
- $92.43B
- P/E
- 14.3x
- Volume
- 2.15M
- Fwd P/E
- 13.3x
- Beta
- 1.11
- Div yield
- 0.71%
- P/S
- 1.2x
- P/B
- 291.3x
- Profit margin
- +8.8%
- Op margin
- +15.2%
- ROE
- +136.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
$7.57 expected
Revenue
No comparable estimate
FY2026 guidance
$77.00B to $79.50B
No comparable estimate
Reports Oct 23, 2026, in 40 days
EPS expected
$5.83 to $7.35
Revenue expected
20 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $19.16B | $19.51B | $19.11B | $20.23B |
| Cost of what it sold | $11.15B | $11.34B | $16.25B | $17.16B |
| Gross profit | $8.02B | $8.18B | $2.86B | $3.07B |
| What it spent | ||||
| Sales and admin | $7.86B | $8.36B | — | — |
| Other operating costs | -$2.81B | -$3.36B | $16.25B | $17.16B |
| Total operating expenses | $5.05B | $5.00B | $16.25B | $17.16B |
| What was left | ||||
| Operating profit | $2.96B | $3.18B | $2.86B | $3.07B |
| Interest on debt | $561.0M | $572.0M | $584.0M | $599.0M |
| Profit before tax | $2.42B | $2.67B | $2.29B | $2.49B |
| Tax | $515.0M | $509.0M | $430.0M | $564.0M |
| Net profit | $1.64B | $1.88B | $1.62B | $1.70B |
| EBITDA | $3.87B | $4.16B | $3.80B | $4.01B |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
HCA CEO Sam Hazen: Mission must ‘earn’ community trust
NeutralSep 12HCA Healthcare, Inc. $HCA Stake Raised by National Pension Service
Leans bullishSep 11Tidal Investments LLC Has $26.98 Million Stock Position in HCA Healthcare, Inc. $HCA
Leans bullishSep 10HCA Healthcare, Inc. $HCA is Darsana Capital Partners LP's 6th Largest Position
BullishSep 10HCA Healthcare (NYSE:HCA) Trading 5.3% Higher - Should You Buy?
Leans bullishSep 9HighTower Advisors LLC Increases Stock Position in HCA Healthcare, Inc. $HCA
Leans bullishSep 9185,804 Shares in HCA Healthcare, Inc. $HCA Bought by VIRGINIA RETIREMENT SYSTEMS ET Al
BullishSep 7Paralel Advisors LLC Makes New $1.90 Million Investment in HCA Healthcare, Inc. $HCA
Leans bullishSep 7
Macro
21 macro signals shaping HCA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results